Biomarker-driven immunotherapy for precision medicine in prostate cancer.

MLA

Ottini, Arianna, et al. “Biomarker-Driven Immunotherapy for Precision Medicine in Prostate Cancer.” Personalized Medicine, vol. 19, no. 1, Jan. 2022, pp. 51–66. EBSCOhost, https://doi.org/10.2217/pme-2021-0079.

APA

Ottini, A., Sepe, P., Beninato, T., Claps, M., Guadalupi, V., Verzoni, E., Giannatempo, P., Baciarello, G., de Braud, F., & Procopio, G. (2022). Biomarker-driven immunotherapy for precision medicine in prostate cancer. Personalized Medicine, 19(1), 51–66. https://doi.org/10.2217/pme-2021-0079

Chicago

Ottini, Arianna, Pierangela Sepe, Teresa Beninato, Mélanie Claps, Valentina Guadalupi, Elena Verzoni, Patrizia Giannatempo, Giulia Baciarello, Filippo de Braud, and Giuseppe Procopio. 2022. “Biomarker-Driven Immunotherapy for Precision Medicine in Prostate Cancer.” Personalized Medicine 19 (1): 51–66. doi:10.2217/pme-2021-0079.